Product NDC: | 51672-4029 |
Proprietary Name: | Warfarin Sodium |
Non Proprietary Name: | Warfarin Sodium |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Warfarin Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4029 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040301 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990715 |
Package NDC: | 51672-4029-7 |
Package Description: | 5000 TABLET in 1 BOTTLE (51672-4029-7) |
NDC Code | 51672-4029-7 |
Proprietary Name | Warfarin Sodium |
Package Description | 5000 TABLET in 1 BOTTLE (51672-4029-7) |
Product NDC | 51672-4029 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Warfarin Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19990715 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | WARFARIN SODIUM |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA] |